Literature DB >> 35514541

NMR spectroscopy of live human asthenozoospermic and normozoospermic sperm metabolism.

Steven Reynolds1, Sarah J Calvert2, Stephen J Walters3, Martyn N Paley1, Allan A Pacey2.   

Abstract

Sperm motility varies between ejaculates from different men and from individual men. We studied normozoospermic and asthenozoospermic ejaculates after density-gradient centrifugation washing (DCG, 80/40%) and compared high- (80%) and low (40%)-motility sperm populations within the same sample. Our objective was to identify differences in endogenous metabolomes and energy metabolism in relation to sperm motility. 1H-Nuclear Magnetic Resonance spectroscopy (NMR) measured the endogenous metabolome of live human sperm. Incubating sperm with 13C-labelled substrates detected energy metabolism by 13C-NMR. The study examined 850 ejaculates and diagnosed asthenozoospermia in 6.1%. DGC was used to wash 160 normozoospermic (N) and 52 asthenozoospermic (A) ejaculates to recover high-motility sperm from the pellet (80N/80A) and low motility from the interface (40N/40A). 1H-NMR spectra, 45(N) and 15(A), were binned and the integrals normalised by sperm concentration. Sperm from 126(N) and 36(A) ejaculates were incubated with either 13C-glucose, 13C-fructose or 13C-pyruvate. 13C-NMR lactate and bicarbonate integrals were normalised by motile or vital sperm concentrations. 1H-NMR spectra choline integrals from the 80A population were significantly lower than the 80N, P  < 0.0001. 13C-substrate conversion to lactate was significantly higher for 40A sperm than 80A sperm when normalised by motile sperm concentration. Bicarbonate integrals were sporadically observed. Sperm from asthenozoospermic ejaculates had similar glycolytic requirements to normozoospermic ones, with larger differences observed between 40 and 80% sperm populations. Higher lactate levels produced by 40% sperm may indicate that impaired sperm motility is due to dysregulated energy metabolism. The alteration in choline metabolism provides opportunities to understand the aetiology of asthenozoospermia. Lay summary: How well sperm swim (motility) varies between ejaculates from different men? Normal sperm motility is beneficial to conception and some men diagnosed with infertility have low sperm motility. Sperm metabolise molecules to produce the energy required for motility. We measured concentrations of molecules within sperm and metabolism of molecules given to sperm and related these to the proportion of motile sperm. The study examined 850 sperm samples and found low motility in 6.1%. Metabolism of molecules given to sperm was similar between low and normal motility sperm samples. However, when the most motile sperm were separated from the rest, they were more efficient in metabolising these molecules to achieve motility. Lower concentrations of a molecule called choline were found in low-motility sperm samples compared to normal samples. Choline is associated with cell membranes, energy metabolism and oxidative stress, which may give opportunities to understand the causes of low motility. © The authors.

Entities:  

Keywords:  NMR; asthenozoospermia; human sperm; metabolomics; motility; nuclear magnetic resonance spectroscopy

Mesh:

Substances:

Year:  2022        PMID: 35514541      PMCID: PMC9066949          DOI: 10.1530/RAF-21-0101

Source DB:  PubMed          Journal:  Reprod Fertil        ISSN: 2633-8386


  36 in total

1.  A sperm-specific proteome-scale metabolic network model identifies non-glycolytic genes for energy deficiency in asthenozoospermia.

Authors:  Arvand Asghari; Sayed-Amir Marashi; Naser Ansari-Pour
Journal:  Syst Biol Reprod Med       Date:  2017-01-13       Impact factor: 3.061

Review 2.  Genetic aspects of idiopathic asthenozoospermia as a cause of male infertility.

Authors:  Zohreh Heidary; Kioomars Saliminejad; Majid Zaki-Dizaji; Hamid Reza Khorram Khorshid
Journal:  Hum Fertil (Camb)       Date:  2018-09-09       Impact factor: 2.767

3.  Metabolomic signature of the seminal plasma in men with severe oligoasthenospermia.

Authors:  Magalie Boguenet; Cinzia Bocca; Pierre-Emmanuel Bouet; Orianne Serri; Stéphanie Chupin; Lydie Tessier; Odile Blanchet; Hady El Hachem; Juan Manuel Chao de la Barca; Pascal Reynier; Pascale May-Panloup
Journal:  Andrology       Date:  2020-08-31       Impact factor: 3.842

4.  Lifestyle and semen quality: role of modifiable risk factors.

Authors:  Joanna Jurewicz; Michał Radwan; Wojciech Sobala; Danuta Ligocka; Paweł Radwan; Michał Bochenek; Wojciech Hanke
Journal:  Syst Biol Reprod Med       Date:  2013-09-30       Impact factor: 3.061

5.  Modifiable and non-modifiable risk factors for poor semen quality: a case-referent study.

Authors:  A C Povey; J-A Clyma; R McNamee; H D Moore; H Baillie; A A Pacey; N M Cherry
Journal:  Hum Reprod       Date:  2012-06-12       Impact factor: 6.918

Review 6.  Genetic underpinnings of asthenozoospermia.

Authors:  Chaofeng Tu; Weili Wang; Tongyao Hu; Guangxiu Lu; Ge Lin; Yue-Qiu Tan
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-11-06       Impact factor: 4.690

7.  Oxidative damage: the biochemical mechanism of cellular injury and necrosis in choline deficiency.

Authors:  Marisa G Repetto; Georgina Ossani; Alberto J Monserrat; Alberto Boveris
Journal:  Exp Mol Pathol       Date:  2009-11-12       Impact factor: 3.362

Review 8.  Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors.

Authors:  Ashish Verma; Ishan Kumar; Nimisha Verma; Priyanka Aggarwal; Ritu Ojha
Journal:  BBA Clin       Date:  2016-04-12

Review 9.  Oxidative phosphorylation versus glycolysis: what fuel do spermatozoa use?

Authors:  Stefan S du Plessis; Ashok Agarwal; Gayatri Mohanty; Michelle van der Linde
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

10.  Seminal Fluid Metabolomic Markers of Oligozoospermic Infertility in Humans.

Authors:  Federica Murgia; Valentina Corda; Marianna Serrenti; Valeria Usai; Maria Laura Santoru; K Joseph Hurt; Mauro Passaretti; Maria Carla Monni; Luigi Atzori; Giovanni Monni
Journal:  Metabolites       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.